dihexa safety concerns hgf c-met cancer risk Frontiers Combination of HGF/MET-targeting agents and
Combination of HGF MET targeting agents and other therapeutic strategies in cancer ScienceDirect What is dihexa, its mechanism of action via the HGF c Met pathway, and its safety and clinical use? Targeting the HGF c MET pathway in advanced pancreatic cancer: a key element of treatment that limits primary tumour growth and eliminates metastasis British Journal of Cancer Correlation between hypoxia and HGF c MET expression in the management of pancreatic cancer ScienceDirect Targeting cancer associated fibroblast activated HGF c MET pathway inhibits extrahepatic cholangiocarcinoma progression and restores gemcitabine therapeutic sensitivity ScienceDirect
Pay in 4 interest-free payments of $6.96 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6



